Ostomies and Fistulas: a Collaborative Approach

Total Page:16

File Type:pdf, Size:1020Kb

Ostomies and Fistulas: a Collaborative Approach NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #33 Carol Rees Parrish, RD, MS, Series Editor Ostomies and Fistulas: A Collaborative Approach Kate Willcutts Katie Scarano Carolyn W. Eddins Management of patients with ostomies can be challenging to say the least; the manage- ment of those with fistulas is even more so. Dietary management of patients with fistu- las can often make the difference between healing versus a prolonged illness. In the past, 40%–65% of people with enterocutaneous fistulas died from associated complica- tions, including malnutrition, however, mortality is now down to 5%–20%. Dietary restrictions for patients with ostomies are based on patient surveys and anecdotal evi- dence. The purpose of this article is to discuss nutritional therapy and skin care of patients with ostomies and fistulas. INTRODUCTION are different from ostomies in many ways; fistulas are stomies are surgically created openings from the not intentionally created and the mortality rate and risk intestine to the skin (Figure 1). They are classi- of complications is much higher. Fistulas can originate Ofied based on their location in the intestine: from any part of the gastrointestinal (GI) tract. One jejunostomy, ileostomy, and colostomy. There are an type of fistula, the enterocutaneous (EC) fistula, is estimated 750,000 people in the US with ostomies; the similar to an ostomy in terms of the nutritional man- number of people with fistulas is much lower. Fistulas agement and enterostomal care. Of note, jejunostomy and ileostomy fluid is called effluent; effluent becomes “stool” if it exits from anywhere in the colon. Kate Willcutts MS, RD, CNSD, Nutrition Support Spe- cialist, University of Virginia Health System, Digestive Health Center of Excellence, Charlottesville, VA. Katie OSTOMIES Scarano BS, RN, CWOCN, Coordinator Wound Man- agement Center, MetroWest Medical Center, Fram- Nutritional management depends on the type of ingham, MA. Carolyn W. Eddins, MSN, FNP, ostomy. Regardless of the type of ostomy, most sur- CWOCN, Advanced Practice Nurse, University of Vir- geons will initiate nutrition via the GI tract when the ginia Health System, Charlottesville, VA. ostomy starts working. However, earlier enteral nutri- PRACTICAL GASTROENTEROLOGY • NOVEMBER 2005 63 Ostomies and Fistulas NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #33 location of the ostomy in the GI tract is essential in determining the appropriate nutritional regimen. For example, a proximal ileostomy may require prolonged intravenous fluids and electrolytes, whereas a distal ileostomy most likely will not. COLOSTOMY Colostomies are the most common type of ostomy, and are classified as ascending, transverse, descending or sigmoid. The most common type of colostomy is the descending or sigmoid colostomy. See Figures 2–5 for examples of each type of colostomy. Figure 1. Stoma Nutritional management of colostomies is the sim- plest of all types of ostomies. Colostomies start func- tion has not been shown to be harmful. Nutrition is usu- tioning 2–5 days after surgery (1). Typically, colostomy ally started by mouth, or in some cases tube feedings output ranges from 200–600 mL/day. There is no evi- will be initiated. Generally, the greater the length of dence to support a specialized diet for patients with functional bowel remaining, the fewer absorption prob- colostomies of any type, a regular diet is appropriate. In lems the patient will have. Knowledge of the specific fact, a large survey conducted among people with ostomies found that 85% did not restrict their diets at all (2). However, because of bacterial fermentation in the colon, some patients may choose to avoid foods that cause undesirable gas production. Possible gas and odor causing foods (based on anecdotal reports) are listed in Table 1. Although rare, hydration can be an issue in patients with minimal remaining colon, as in the case of an ascending colostomy. These patients can usually manage the additional fluid loss by increasing fluid intake per os in conjunction with some gut slow- ing medications; IV hydration is seldom necessary. Figure 2. Ascending Figure 3. Transverse colostomy colostomy ILEOSTOMY Ileostomies will normally start functioning within 24 hours after surgery (1) (Figure 6). Initially, expected output is >1 liter per day. After a week or more of this high volume output, the effluent thickens and the total volume gradually falls to roughly 600 mL/day. Main- taining adequate hydration in patients with ileostomies may require increased consumption of fluids (an addi- tional 500–750 mL per day) (3). As with colostomies, specialized diets are not nec- essary for patients with ileostomies. Ileostomies gen- Figure 4. Descending Figure 5. Sigmoid erally do not result in as much gas or odor production colostomy colostomy (continued on page 66) 64 PRACTICAL GASTROENTEROLOGY • NOVEMBER 2005 Ostomies and Fistulas NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #33 (continued from page 64) as colostomies due to the Table 1 lower bacterial content of Foods that may alter gas production, odor and viscosity the small bowel. How- ever, if gas is a problem, Gas-forming foods patients may need to Legumes (dried beans) Carbonated beverage avoid activities that Broccoli Garlic increase the amount of Brussels sprouts Onion swallowed air, such as Cabbage Eggs smoking, chewing gum, Onion Fish drinking through a straw Odor-producing foods Figure 6. Distal Ileostomy (3), or consuming carbon- ated beverages. Salt Asparagus Eggs intake should be liberal- Broccoli Fish Brussels sprouts Garlic ized due to higher sodium Cabbage Onion losses in ileostomy output. People with ostomies Cauliflower report that certain foods tend to thicken the stool (Table 1). Other foods have been reported to cause Stool thickening foods “blockages” at the ileostomy site. These foods include high fiber or difficult to digest foods such as: nuts, Cheese Pasta popcorn, dried fruits, raw cabbage, corn, celery, White bread Pretzels coconut, apples with peels, and grapes. A blockage is White rice Creamy peanut butter more likely to occur in a patient with an ileostomy than Marshmallows a colostomy due to the smaller diameter of the ileal lumen. To decrease the risk of blockage, patients are intravenous fluids and electrolytes, if not total par- instructed to chew their food well and to introduce enteral nutrition at least initially. To minimize GI secre- fibrous foods in small amounts one at a time gradually tions and ostomy output, oral fluid intake needs to be increasing their intake (3). limited. Patients with jejunostomies should be pre- Patients with ileostomies often require gut-slowing scribed gut-slowing medications to lengthen transit medications such as Lomotil or Imodium during the time and maximize nutrient absorption, along with a adaptation phase. If these prove inadequate, stronger proton-pump inhibitor to decrease gastric secretions. medications such as paregoric or codeine may be Gut slowing not only aids in increasing transit time, but needed. If hydration or electrolyte balance cannot be can also help with rapid gastric emptying that can lead maintained with a regular diet and gut-slowing medica- to malabsorption secondary to the denaturing of pan- tions, oral rehydration therapy (ORT) can be attempted. creatic enzymes. Monitoring electrolytes, sodium in ORT is readily available, brands include Pedialyte, Cer- particular, is important due to losses in jejunostomy alyte and the World Health Organization (WHO) packet output. As the bowel adapts with time, it may become (4); homemade recipes can be found in the article on better able to absorb fluids and electrolytes. Oral rehy- short bowel syndrome in the September 2005 issue of dration therapy may be a useful adjunct in these Practical Gastroenterology (5). If ORT is unsuccessful, patients as well. A more thorough review on the short supplemental intravenous fluids will be necessary. gut syndrome is available elsewhere (5). JEJUNOSTOMY OSTOMY SKIN CARE AND Patients with jejunostomies are managed in a similar EFFLUENT/STOOL CONTAINMENT way to those with short gut, in fact, the patient may Skin care and containment of ostomy output are major have a short gut. These patients will most likely need considerations in the overall rehabilitation of the per- 66 PRACTICAL GASTROENTEROLOGY • NOVEMBER 2005 Ostomies and Fistulas NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #33 Table 2 Factors Influencing Pouch Selection • Stoma size and shape • Location of stomal opening • Characteristics of stomal output • Skin integrity around stoma • Pouch wear time • Manual dexterity of patient • Visual acuity of patient • Cost of pouches Figure 7. Ostomy products Table 3 Ostomy Product Supply Companies son who has undergone surgery resulting in the cre- Coloplast www.us.coloplast.com ation of an ostomy. An effective pouching system pro- tects the skin, contains the effluent/stool and odor, and Convatec www.convatec.com remains securely attached to the skin for a dependable amount of time. Hollister, Inc. www.hollister.com A solid skin barrier (wafer) and the collection device (pouch) are the components of the pouching Marlen www.marlenmfg.com system (Figure 7). The most important part of the device is the skin barrier that interfaces with the skin extended-wear skin barrier, whereas a patient with a and the pouch. This barrier protects the skin from fecal colostomy and a lower volume of more solid stool may drainage and seals the pouch to provide a wear time of do well with a regular skin barrier. approximately 3 to 7 days. Wear time is primarily Barrier shape can affect adhesion potential. A flat influenced by 2 factors—the rate of breakdown of the skin barrier is level with the skin surface whereas a barrier, and adhesion adequacy of the barrier to the convex shape has an outward curve. The decision as to skin. The volume and consistency of the ostomy out- which type is best depends on the stoma height and put, and the specific characteristics of the solid barrier location, and the presence of creases or folds when the chosen, determine the rate of barrier breakdown.
Recommended publications
  • Routine Use of Feeding Jejunostomy in Pancreaticoduodenectomuy: A
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 95 JuneSeptember 2020 2020 doi:10.20944/preprints202006.0114.v1 doi:10.20944/preprints202006.0114.v2 Routine use of Feeding Jejunostomy in Pancreaticoduodenectomuy: A Metaanalysis. DR.Bhavin Vasavada Consultant HepatoPancreaticobiliary and Liver Transplant Surgeon, Shalby Hospitals, Ahmedabad. Email: [email protected] Dr.Hardik Patel Consultant HepatoPancreaticobiliary and Liver Transplant Surgeon, Shalby Hospitals, Ahmedabad. Conflict of Interests: none. Funding disclosure: none. Abbreviations: Post operative pancreatic fistula (POPF), total parentral nutrition (TPN), Surgical site infections. (SSI) Keywords: Pancreaticoduodenectomy; feeding jejunostomy; morbidity; mortality Abstract: Aims and objectives: The primary aim of our study was to evaluate morbidity and mortality following feeding jejunostomy in pancreaticoduodenectomy compared to the control group. We © 2020 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 95 JuneSeptember 2020 2020 doi:10.20944/preprints202006.0114.v1 doi:10.20944/preprints202006.0114.v2 also evaluated individual complications like delayed gastric emptying, post operative pancreatic fistula, superficial and deep surgical site infection. We also looked for time to start oral nutrition and requirement of total parentral nutrition. Material and Methods: The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and MOOSE guidelines. [9,10]. We searched pubmed, cochrane library, embase, google scholar with keywords like “feeding jejunostomy in pancreaticodudenectomy”, “entral nutrition in pancreaticoduodenectomy, “total parentral nutrition in pancreaticoduodenectomy’, “morbidity and mortality following pancreaticoduodenectomy”. Two independent authors extracted the data (B.V and H.P). The meta-analysis was conducted using Open meta-analysis software.
    [Show full text]
  • Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis
    ORIGINAL ARTICLE pISSN 2234-778X •eISSN 2234-5248 J Minim Invasive Surg 2015;18(2):48-52 Journal of Minimally Invasive Surgery Laparoscopic Truncal Vagotomy and Gatrojejunostomy for Pyloric Stenosis Jung-Wook Suh, M.D.1, Ye Seob Jee, M.D., Ph.D.1,2 Department of Surgery, 1Dankook University Hospital, 2Dankook University School of Medicine, Cheonan, Korea Purpose: Peptic ulcer disease (PUD) remains one of the most prevalent gastrointestinal diseases and Received January 27, 2015 an important target for surgical treatment. Laparoscopy applies to most surgical procedures; however Revised 1st March 9, 2015 its use in elective peptic ulcer surgery, particularly in cases of pyloric stenosis, has not been popular. 2nd March 28, 2015 The aim of this study was to describe the role of laparoscopic surgery and an easily performed Accepted April 20, 2015 procedure for pyloric stenosis. We accordingly performed laparoscopic truncal vagotomy with gastrojejunostomy in 10 consecutive patients with pyloric stenosis. Corresponding author Ye Seob Jee Methods: Data were collected prospectively from all patients who underwent laparoscopic truncal Department of Surgery, Dankook vagotomy with gastrojejunostomy from August 2009 to May 2014 and reviewed retrospectively. University Hospital, Dankook Results: A total of 10 patients underwent laparoscopic trucal vagotomy with gastrojejunostomy for University School of Medicine, 119, peptic ulcer obstruction from August 2009 to May 2014 in ○○ university hospital. The mean age was Dandae-ro, Dongnam-gu, Cheonan 62.6 (±16.4) years old and mean BMI was 19.3 (±2.5) kg/m2. There were no conversions to open 330-714, Korea surgery and no occurrence of intra-operative complications.
    [Show full text]
  • Tube Feeding Protocol: Supporting an Individual with a Feeding Tube
    Tube Feeding Protocol: Supporting an Individual with a Feeding Tube Introduction Some people may be unable to take foods or fluids by mouth due to dysphagia. Others may require supplementation because they are unable to take sufficient foods or fluids by mouth, and formula delivered through a feeding tube may provide them with much needed additional nutrients. It is helpful if guidelines (A Tube Feeding Protocol) are in place prior to the need for this intervention. Below are some suggested guidelines for supporting an Individual with a feeding tube. Information to be documented by the physician The reason (medical diagnosis) requiring feeding tube insertion Type of feeding tube inserted Types of feeding tubes The Nasogastric Tube (NG tube): Passed into either nostril, down the esophagus and into the stomach. This is used for short term feedings. The Gastrostomy tube (G - tube or PEG): Surgically placed through the abdominal wall into the stomach. The tube will be located below the rib cage and to the left. The Jejunostomy tube (J - tube or PEJ): Surgically implanted in the upper portion of the jejunum (Part of the small intestine.) The tube will be located lower in the abdomen and more toward the center than the G – tube. Feedings through a J – tube must always be by pump. The Gastrostomy-Jejunostomy (GJ - tube): Surgically placed in the stomach, like the G – tube, but the tubing is longer, the end is in the jejunum, and there are two ports. Feeding technique Feeding techniques Bolus: A set amount of formula is given over a short period of time via syringe.
    [Show full text]
  • Laparoscopic Witzel Jejunostomy
    [Downloaded free from http://www.journalofmas.com on Wednesday, February 12, 2020, IP: 93.55.127.222] How I do It Laparoscopic Witzel jejunostomy Marco Lotti1, Michela Giulii Capponi2, Denise Ferrari2, Giulia Carrara1, Luca Campanati2, Alessandro Lucianetti2 1Advanced Surgical Oncology Unit, Department of General Surgery 1, Papa Giovanni XXIII Hospital, Bergamo, Italy, 2Department of General Surgery 1, Papa Giovanni XXIII Hospital, Bergamo, Italy Abstract The placement of a feeding jejunostomy can be indicated in malnourished patients with gastric and oesophagogastric junction cancer to allow for enteral nutritional support. In these patients, the jejunostomy tube can be suitably placed at the time of staging laparoscopy. Several techniques of laparoscopic jejunostomy (LJ) have been described, yet the Witzel approach remains neglected, due to the perceived difficulty of suturing the bowel around the tube and securing them to the abdominal wall. Here, we describe a novel technique for LJ, using a single barbed suture for securing the bowel and tunnelling the jejunostomy catheter according to the Witzel approach. Keywords: Enteral nutrition, oesophagogastric junction cancer, gastric cancer, jejunostomy, laparoscopic jejunostomy Address for correspondence: Dr. Marco Lot, Advanced Surgical Oncology Unit, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy. E‑mail: [email protected] Received: 17.10.2019, Accepted: 11.11.2019, Published: 11.02.2020 INTRODUCTION use of peel-away introducers, sealing the entry site with barbed
    [Show full text]
  • Short Bowel, Short Answer?
    478 Nightingale 8 Van Doorn L, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, 10 Yamaoka Y, Kodama T, Kashima K, et al. Variants of the 3' region of the vacA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58–66. cagA gene in Helicobacter pylori isolates from patients with diVerent H. 9 Rudi J, Kolb C, Maiwald M, et al. Diversity of Helicobacter pylori vacA and pylori-associated diseases. J Clin Microbiol 1998;36:2258–63. cagA genes and relationship to VacA and CagA protein expression, 11 Blaser MJ. Helicobacters are indigenous to the human stomach: duodenal cytotoxin production and associated diseases. J Clin Microbiol 1998;36: ulceration is due to changes in gastric microecology in the modern era. Gut 944–8. 1998;43:721–7. See article on page 559 Short bowel, short answer? from their stoma.14 This is because of loss of normal daily intestinal secretions (about 4 litres/24 hours), rapid gastric emptying and rapid small bowel transit.15 If a patient has less than 100 cm jejunum remaining and a stoma he/she is The paper by Jeppsen et al (see page 559) shows that likely, as a minimum, to need long term parenteral saline.14 glucagon-like peptide-2 (GLP-2) concentrations are low in This requirement does not reduce with time.3 Patients patients lacking an ileum and colon. This is not an with a retained colon do not have these problems and, unexpected finding as the L cells that produce GLP-2 are owing to functional adaptation, nutrient absorption situated in the ileum and colon.
    [Show full text]
  • Pancreaticoduodenectomy After Roux-En-Y Gastric Bypass: a Novel Reconstruction Technique
    6 Technical Note Pancreaticoduodenectomy after Roux-en-Y Gastric Bypass: a novel reconstruction technique Malcolm Han Wen Mak, Vishalkumar G. Shelat Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore Correspondence to: Dr. Malcolm Han Wen Mak. Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. Email: [email protected] Abstract: The obesity epidemic continues to increase around the world with its attendant complications of metabolic syndrome and increased risk of malignancies, including pancreatic malignancy. The Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure for obesity and its comorbidities. We describe a report wherein a patient with previous RYGB was treated with a novel reconstruction technique following a pancreaticoduodenectomy (PD). A 59-year-old male patient with previous history of RYGB was admitted with painless progressive jaundice. Imaging revealed a distal common bile duct stricture and he underwent PD. There are multiple options for reconstruction after PD in patients with previous RYGB. The two major decisions for pancreatic surgeon are: (I) resection/preservation of remnant stomach and (II) resection/ preservation of original biliopancreatic limb. This has to be tailored to the patient based on the intraoperative findings and anatomical suitability. In our patient, the gastric remnant was preserved, and distal part of original biliopancreatic limb was anastomosed to the stomach as a venting anterior gastrojejunostomy. A distal loop of small bowel was used to reconstruct the pancreaticojejunostomy and hepaticojejunostomy and further distally a new jejunojejunostomy performed. The post-operative course was uneventful, and the patient was discharged on 7th day.
    [Show full text]
  • Focus on Laparoscopic Feeding Jejunostomy Operative Technique
    Surgical Technique World Journal of Surgery and Surgical Research Published: 31 Mar, 2020 Focus on Laparoscopic Feeding Jejunostomy Operative Technique Sorin Cimpean1*, Byabene Gloire A Dieu2 and Guy Bernard Cadiere1 1Department of Digestive Surgery, Saint Pierre University Hospital, Brussels, Belgium 2Department of Surgery, Panzi Hospital, Democratic Republic of the Congo Abstract The feeding jejunostomy placement is a surgical operation in which the patient is nourished through a feeding tube placed in the jejunum. Laparoscopic jejunostomy feeding tube placement can be standardized due to the regular anatomy. We developed a technique by laparoscopic approach a serosal tunnel (according to Witzel open technique) of the feeding tube using accessible materials. Introduction The feeding jejunostomy placement is a surgical operation in which the patient is nourished through a feeding tube placed in the jejunum, the first part of the small bowel. The first to accomplish a jejunostomy for nutritional purposes was Bush in 1858 in a patient with non-operable gastric cancer [1]. In 1891 Witzel described the most well-known technique for jejunostomy, and it has undergone diverse modification, such as those adopted by Coffey and Albert. A definitive jejunostomy is that done by the Roux-en-Y technique [2]. By 1990 minimal invasive surgery had appeared, and diverse options for jejunostomy by laparoscopy were described [3-8]. The feeding tube is a tube that requires an opening to be created between the skin of the abdomen and the wall of the jejunum. Connected directly to the patient's digestive tract, the feeding tube provides water, nutrients, and medication if needed. Feeding jejunostomy is essential when a patient is unable to have an oral alimentation.
    [Show full text]
  • Intestinal Transplantation
    The new england journal of medicine review article Current Concepts Intestinal Transplantation Thomas M. Fishbein, M.D. From the Georgetown Transplant Institute, he results of intestinal transplantation have improved over Georgetown University Hospital, Wash- the past decade. During this period, the number of intestinal transplant pro- ington, DC. Address reprint requests to 1 Dr. Fishbein at the Georgetown Trans- cedures performed in North America has increased by a factor of three. In plant Institute, 2 Main, Georgetown Uni- T 2008, a total of 185 intestinal transplantations were performed in the United States, versity Hospital, 3800 Reservoir Rd. NW, and 221 patients were registered on the waiting list as of June 2009 (http://optn. Washington, DC 20007, or at tmf8@gunet. georgetown.edu. transplant.hrsa.gov). Early attempts at transplantation were hindered by technical and immunologic complications that led to graft failure or death. As a result of recent N Engl J Med 2009;361:998-1008. surgical advances, control of acute cellular rejection, and a decrease in lethal infec- Copyright © 2009 Massachusetts Medical Society. tions, the rate of patient survival at 1 year now exceeds 90% at experienced centers. Although long-term follow-up data are still lacking, the role of intestinal transplan- tation in the treatment of patients with gut failure is becoming clearer. Parenteral nutrition is currently the primary maintenance therapy for patients in whom intestinal absorptive function has failed. Transplantation is offered to patients with irreversible gut failure who have one of three problems: complications of par- enteral nutrition, an inability to adapt to the quality-of-life limitations posed by in- testinal failure, or a high risk of death if the native gut is not removed (as in the case of unresectable mesenteric tumors or chronic intestinal obstruction).
    [Show full text]
  • Enteral Nutrition in Pancreaticoduodenectomy: a Literature Review
    Nutrients 2015, 7, 3154-3165; doi:10.3390/nu7053154 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Enteral Nutrition in Pancreaticoduodenectomy: A Literature Review Salvatore Buscemi 1,2,†,*, Giuseppe Damiano 3, Vincenzo D. Palumbo 2,3,4, Gabriele Spinelli 2, Silvia Ficarella 2, Giulia Lo Monte 5, Antonio Marrazzo 2 and Attilio I. Lo Monte 2,3,† 1 School of Oncology and Experimental Surgery, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy 2 Department of Surgical, Oncological and Dentistry Studies, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mails: [email protected] (V.D.P.); [email protected] (G.S.); [email protected] (S.F.); [email protected] (A.M.); [email protected] (A.I.L.M.) 3 “P.Giaccone”, University Hospital, School of Medicine, School of Biotechnology, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mail: [email protected] 4 School of Surgical Biotechnology and Regenerative Medicine in Organ Failure, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy 5 School of Biotechnology, University of Palermo, via Del Vespro 129, 90127 Palermo, Italy; E-Mail: [email protected] † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +39 3357593376. Received: 30 November 2014 / Accepted: 15 April 2015 / Published: 30 April 2015 Abstract: Pancreaticoduodenectomy (PD) is considered the gold standard treatment for periampullory carcinomas. This procedure presents 30%–40% of morbidity. Patients who have undergone pancreaticoduodenectomy often present perioperative malnutrition that is worse in the early postoperative days, affects the process of healing, the intestinal barrier function and the number of postoperative complications.
    [Show full text]
  • COMPLICATIONS of Bile Duct Recon
    Biliary Tract Complications in Liver Transplantation Under Cyclosporin-Steroid Therapy S. Iwatsuki, B. W. Shaw, Jr., and T. E. Starzl OMPLICATIONS of bile duct recon­ tube (usually infant feeding tube) was used as a stent. one C struction in liver transplantation are end passing through the papilla of Vater into the duode­ num (choledocho-choledochostomy with straight tube more frequent than those of vascular anasto­ stent. C-C-S), moses.I. 2 In earlier times, unrecognized bile End-to-side choledocho-jejunostomy in Roux-en-Y duct obstruction was frequently mistaken for with a straight tube stent (C-J-S) became the first choice graft rejection, and unwise decisions to when the recipient's bile duct was absent (in biliary increase immunosuppression often resulted in atresia) or diseased (in sclerosing cholangitis. bile duct cancer. or secondary biliary cirrhosis). When the donor's fatal septic complications. In other cases, bil­ common bile duct was used for bile duct reconstruction. iary leakage and peritonitis in the early post­ the gallbladder was always removed, operative period limited the adequate use of Cholecysto-jejunostomy in Roux-en-Y (Cy-J). tube immunosuppression, resulting in acute graft cholecystostomy. or tube choledochostomy were used only rejection superimposed on serious septic bil­ when the operation was so difficult and the patient was so unstable that better bile duct reconstruction could not be iary peritonitis. performed. The problems caused by biliary complica­ tions under conventional immunosuppression Case Materials have been reported in our series I and in the During the 29 months between March 1980 and July Cambridge series.2 These, directly or indirect­ 1982.78 patients received 90 orthotopic liver transplanta­ ly, caused death in many cases.
    [Show full text]
  • Appendix 10: Administering Drugs Via Feeding Tubes
    Appendix 10: Administering drugs via feeding tubes Administering drugs via feeding tubes is generally an unlicensed activity. There is little published data and most recommendations are theoretical and/or based on local policy. An alternative licensed option may therefore be preferable, e.g. rectal or parenteral formulations. However, if given by tube, there is a range of possibilities (Figure A10.1). Guidance should be sought from a pharmacist regarding which option is feasible or most appropriate. There are several types of feeding tubes (Box A10.A). These can be further classified according to lumen size (French gauge), number of lumens (single or multiple) and length of use (short- term, long-term/fixed). Figure A10.1 4-step ladder for drug administration by feeding tubesa Injectable formulation via tube Extemporaneous oral solution/suspension prepared by local pharmacy Crushed capsule/tablet contents fully dispersed Commercial oral solution/suspension or dispersible tablet a. Step 1 is the preferred option; for further explanation, see Choosing a suitable formulation. Box A10.A Main types of feeding tubes Nasogastric (NG), inserted into the stomach via the nose. Nasojejunal (NJ), inserted into the jejunum via the nose. Percutaneous endoscopic gastrostomy (PEG), inserted into the stomach via the abdominal wall. Percutaneous endoscopic jejunostomy (PEJ), inserted into the jejunum via the abdominal wall. Percutaneous endoscopic gastro-jejunostomy (PEGJ), inserted into the jejunum via the abdominal wall and through the stomach. © 2002 Palliativedrugs.com Ltd In addition to the general guidance (Box A10.B), the following should be considered when giving drugs via feeding tubes: • sterility with jejunal tube, use sterile water because the acid barrier in the stomach is bypassed; 1 some centres use an aseptic technique to reduce the risk of infective diarrhoea • site of drug delivery with jejunal tubes, absorption may be unpredictable because the tube may extend beyond the main site of absorption of the drug, e.g.
    [Show full text]
  • Feeding Tube
    When you have a Feeding Tube A guide for you, family and friends 1 Tube Feeding Important Information . This book belongs to: _________________________________ Doctor who put tube in: _______________________________ Family Doctor: ________________________________________ Dietitian: _____________________________________________ Nurse: ________________________________________________ Pharmacy: ____________________________________________ Specialty Food Shop: __________________________________ Equipment Supplier: ___________________________________ Formula Supplier: ______________________________________ Other Supplies: ________________________________________ Other Information: _____________________________________ Copyright: ©1995-2012 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying or otherwise, without the prior permission of St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada. For more information contact: St. Joseph’s Healthcare Hamilton, Nutrition Services Department, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6 Telephone: 905-522-4941. Acknowledgements: We would like to acknowledge and thank the members of the Regional Enteral Feeding Committee: Bayshore Healthcare, Care Plus, Community Rehab, Hamilton Health Sciences, Hamilton Niagara Haldimand Brant Community Care Access Centre, St. Joseph’s Home Care, St. Joseph’s Healthcare Hamilton, St. Peter’s Hospital, Victorian Order of Nurses, for
    [Show full text]